Raman Bahal
Associate Professor/Pharmaceutical Science
Storrs Mansfield
Are you Raman Bahal?
How to update your information.
Scholarly Contributions
69 Scholarly Contributions
Targeting the Liver with Nucleic Acid Therapeutics for the Treatment of Systemic Diseases of Liver Origin
2024
Research Type: Other Scholarly Work
Multivalent Lactobionic Acid and N-Acetylgalactosamine-Conjugated Peptide Nucleic Acids for Efficient In Vivo Targeting of Hepatocytes
2023
Research Type: Journal Article
microRNA-33 deficiency in macrophages enhances autophagy, improves mitochondrial homeostasis, and protects against lung fibrosis.
2023
Research Type: Journal Article
Next-generation poly-L-histidine formulations for miRNA mimic delivery
2023
Research Type: Journal Article
Unlocking the potential of chemically modified peptide nucleic acids for RNA-based therapeutics.
2023
Research Type: Journal Article
Targeting genomic DNA for cancer therapy, Invention disclosure submitted
2023
Research Type: Patent and Intellectual Property
Discoidal nano universal platform for efficient delivery of PNAs
2023
Research Type: Patent and Intellectual Property
Nanoparticle-mediated genome editing in single-cell embryos via peptide nucleic acids.
2022
Research Type: Journal Article
New Technologies Bloom Together for Bettering Cancer Drug Conjugates.
2022
Research Type: Journal Article
Head on Comparison of Self- and Nano-assemblies of Gamma Peptide Nucleic Acid Amphiphiles.
2022
Research Type: Journal Article
Targeted Suppression of miRNA-33 Using pHLIP Improves Atherosclerosis Regression.
2022
Research Type: Journal Article
Adverse Drug Reactions and Toxicity of the Food and Drug Administration–Approved Antisense Oligonucleotide Drugs
2022
Research Type: Journal Article
Serine-γPNA, Invader probes, and chimeras thereof: three probe chemistries that enable sequence-unrestricted recognition of double-stranded DNA.
2022
Research Type: Journal Article
Absorption, Distribution, Metabolism, and Excretion of US Food and Drug Administration–Approved Antisense Oligonucleotide Drugs
2022
Research Type: Journal Article
γ Peptide Nucleic Acid-Based miR-122 Inhibition Rescues Vascular Endothelial Dysfunction in Mice Fed a High-Fat Diet.
2022
Research Type: Journal Article
Simultaneous targeting of multiple oncomiRs with phosphorothioate or PNA-based anti-miRs in lymphoma cell lines
2022
Research Type: Journal Article